These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 4930810)

  • 21. Adjuvant activity of mycobacterial fractions. III. Adjuvant effect of cell wall of Mycobacterium bovis BCG on cell-mediated cytotoxicity in mice.
    Taniyama T; Azuma I; Yamamura Y
    Jpn J Microbiol; 1975 Aug; 19(4):255-64. PubMed ID: 811834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor suppression by cell walls of mycobacterium bovis attached to oil droplets.
    Zbar B; Rapp HJ; Ribi EE
    J Natl Cancer Inst; 1972 Mar; 48(3):831-5. PubMed ID: 4333775
    [No Abstract]   [Full Text] [Related]  

  • 23. [Cancer immunotherapy with BCG cell-wall skeleton (author's transl)].
    Azuma I; Yamamura Y
    Tanpakushitsu Kakusan Koso; 1978 May; 23(6):625-40. PubMed ID: 211546
    [No Abstract]   [Full Text] [Related]  

  • 24. Adjuvanticity and delayed-type hypersensitivity by Bacillus Calmette-Guérin (BCG).
    Hiu IJ; Amiel JL
    Experientia; 1972 Aug; 28(8):953-4. PubMed ID: 4561796
    [No Abstract]   [Full Text] [Related]  

  • 25. Efficacy of mycobacterial cell walls as a vaccine against airborne tuberculosis in the Rheusus monkey.
    Ribi E; Anacker RL; Barclay WR; Brehmer W; Harris SC; Leif WR; Simmons J
    J Infect Dis; 1971 May; 123(5):527-38. PubMed ID: 5000470
    [No Abstract]   [Full Text] [Related]  

  • 26. Immunotherapy of cancer: regression of established intradermal tumors after intralesional injection of mycobacterial cell walls attached to oil droplets.
    Zbar B; Ribi E; Meyer T; Azuma I; Rapp HJ
    J Natl Cancer Inst; 1974 May; 52(5):1571-7. PubMed ID: 4364736
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of Micrococcus, BCG and structurally related polysaccharides on the adjuvanticity to a T cell-dependent antigen [proceedings].
    Verloes R; Huygen K; Bechers E; Atassi G; Kanarek L
    Arch Int Physiol Biochim; 1979 Oct; 87(4):860-2. PubMed ID: 93950
    [No Abstract]   [Full Text] [Related]  

  • 28. Hydrosoluble immunostimulants of bacterial and synthetic origins.
    Jollès P
    Experientia; 1976 Jun; 32(6):677-83. PubMed ID: 181265
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cross reactivity of lepromin with other mycobacterial antigens.
    Goihman-Yahr M; Raffel S; Ferraresi RW
    Int J Lepr Other Mycobact Dis; 1968; 36(2):129-43. PubMed ID: 4877112
    [No Abstract]   [Full Text] [Related]  

  • 30. Mycobacterial cell wall components in tumor suppression and regression.
    Ribi EE; Meyer TJ; Azuma I; Zbar B
    Natl Cancer Inst Monogr; 1973 Dec; 39():115-9. PubMed ID: 4595311
    [No Abstract]   [Full Text] [Related]  

  • 31. Structure of Freund's complete and incomplete adjuvants. Relation of adjuvanticity to structure.
    Dvorak AM; Dvorak HF
    Immunology; 1974 Jul; 27(1):99-114. PubMed ID: 4605156
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adjuvant activity of bacterial peptidoglycans on the production of delayed hypersensitivity and on antibody response.
    Nauciel C; Fleck J; Martin JP; Mock M; Nguyen-Huy H
    Eur J Immunol; 1974 May; 4(5):352-6. PubMed ID: 4604064
    [No Abstract]   [Full Text] [Related]  

  • 33. Immunoadjuvant activities of fungal cell walls.
    Kotani S; Watanabe Y; Narita T; Shimono T; Stewart-Tull DE
    Biken J; 1975 Jun; 18(2):135-8. PubMed ID: 1180869
    [No Abstract]   [Full Text] [Related]  

  • 34. [The influence of Mycobacterium bovis BCG-prague, respectively of Mycobacterium smegmatis on the growth of the intratracheally transplanted Deal's sarcoma in guinea pigs (author's transl)].
    Schwartz E; Vincúrová M; Badalik L
    Bratisl Lek Listy; 1975 Sep; 64(3):272-84. PubMed ID: 1098744
    [No Abstract]   [Full Text] [Related]  

  • 35. Rate of antigen catabolism and immunogenicity of [131-I]BGG in mice. I. Action of mycobacterial adjuvants.
    Stark JM
    Immunology; 1970 Sep; 19(3):449-56. PubMed ID: 4919426
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biologically active components from mycobacterial cell walls. IV. Protection of mice against aerosol infection with virulent mycobacterium tuberculosis.
    Ribi E; Meyer TJ; Azuma I; Parker R; Brehmer W
    Cell Immunol; 1975 Mar; 16(1):1-10. PubMed ID: 803876
    [No Abstract]   [Full Text] [Related]  

  • 37. Adjuvant activity of mycobacterial fractions: adjuvant activity of synthetic N-acetylmuramyl-dipeptide and the related compounds.
    Azuma I; Sugimura K; Taniyama T; Yamawaki M; Yamamura Y
    Infect Immun; 1976 Jul; 14(1):18-27. PubMed ID: 820642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adjuvant properties of bacterial cell wall mucopeptides.
    Holton JB; Schwab JH
    J Immunol; 1966 Jan; 96(1):134-8. PubMed ID: 4955258
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of oral administration of lysozyme or digested bacterial cell walls on immunostimulation in guinea pigs.
    Namba Y; Hidaka Y; Taki K; Morimoto T
    Infect Immun; 1981 Feb; 31(2):580-3. PubMed ID: 7216461
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Use of a water-soluble adjuvant fraction from "Mycobacterium smegmatis" with sperm extract to induce autoimmune aspermatogenic orchiepididymitis in guniea pigs (author's transl)].
    Toullet F; Audibert F; Chedid L; Voisin GA
    Ann Immunol (Paris); 1974 Nov; 125(6):901-10. PubMed ID: 4282838
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.